FIGURE 2 from Enhanced Detection of Landmark Minimal Residual Disease in Lung Cancer Using Cell-free DNA Fragmentomics

作者：Siwei Wang, Zhijun Xia, Jing You, Xiaolan Gu, Fanchen Meng, Peng Chen, Wanxiangfu Tang, Hua Bao, Jingyuan Zhang, Xue Wu, Yang Shao, Jie Wang, Xianglin Zuo, Lin Xu, Rong Yin · 年份：2023 · DOI：10.1158/2767-9764.23261303.v1 · 研究领域：Cancer Genomics and Diagnostics、Lung Cancer Treatments and Mutations、Genetics, Bioinformatics, and Biomedical Research

<p>Leave-one-out cross-validation (LOOCV) results of Coxnet model using fragmentomics profiles. <b>A,</b> ROC curves for both 7 days and 6 months postsurgical models. <b>B</b> and <b>C,</b> Barplots for model-predicted risk scores for 7 days and 6 months postsurgical models.</p>